MHP
RMTI icon

Manatuck Hill Partners’s Rockwell Medical RMTI Stock Holding History

Manatuck Hill Partners’s Portfolio RMTI Stock Details RMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,136
Closed -$345K – 110
2019
Q3 		$345K Hold
1,136
– – 0.19% 70
2019
Q2 		$376K Buy
+1,136
New +$577K 0.18% 88

Other funds holding RMTI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
SW
SkyOak Wealth Southfield, Michigan $546M AUM 18.14% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Manatuck Hill Partners's RMTI Position: Q4 2019 in Review

Manatuck Hill Partners sold out of Rockwell Medical (RMTI) in Q4 2019, closing a stake of 1,136 shares — an estimated $345K sold.

Manatuck Hill Partners first reported a position in RMTI in Q2 2019 and held it in 2 quarters. The position peaked at $376K in Q2 2019. 83 funds tracked by Wall St. Rank hold RMTI as of Q4 2019.

  • Manatuck Hill Partners reported no remaining Rockwell Medical position as of Q4 2019 after selling out during the quarter.
  • Manatuck Hill Partners sold 1,136 Rockwell Medical shares in Q4 2019, an estimated $345K.
  • Manatuck Hill Partners first reported a position in Rockwell Medical in Q2 2019 and held it in 2 quarters.
  • Manatuck Hill Partners's Rockwell Medical position peaked at $376K in Q2 2019.
  • 83 funds tracked by Wall St. Rank held Rockwell Medical as of Q4 2019.

Based on Manatuck Hill Partners's 13F filing for Q4 2019, filed 14 Feb 2020.